安裝中文字典英文字典辭典工具!
安裝中文字典英文字典辭典工具!
|
- Pharmacoeconomics: Evaluating the Cost-effectiveness of Medications
Key Concepts in Pharmacoeconomics: Cost-effectiveness Analysis (CEA): CEA compares the costs and outcomes of different treatment options to determine the most cost-effective intervention based on a common outcome measure, such as cost per quality-adjusted life-year (QALY) gained
- Drug use and spending under a formulary informed by cost-effectiveness . . .
We find that a drug formulary informed by cost-effectiveness evidence can be accepted by employers and potentially achieve a better balance between population-level prescription drug affordability and patient-level access to high-value specialty drugs
- A Framework for Using Cost-effectiveness Analysis to Support Pricing . . .
This article proposes a framework for using cost-effectiveness analysis to support pricing and funding decisions for new pharmaceuticals in a context of evolving treatments, prices, and evidence
- Cost-Effectiveness Analysis and the Formulary Decision-Making Process
Within pharmacoeconomics (PE), cost-effectiveness analysis (CEA) is the most commonly used method However, current methodological concerns about CEA have limited its practical contribution to the formulary process Advances in analysis are likely to improve the relevance of CEA over time
- Cost-Effectiveness Analysis of Pharmaceutical Policies: Impact on . . .
This article examines the significance of CEA in evaluating the cost-effectiveness of pharmaceutical interventions and its influence on healthcare policy formulation
- A Framework for Using Cost-effectiveness Analysis to Support Pricing . . .
We propose a framework for using cost-efectiveness analysis to support pricing and funding policies for new pharmaceuticals in multi-comparator indications, some of the key aspects of which evolve over time
- The application of multi-criteria decision analysis in evaluating the . . .
This analysis aims to provide a foundation for the construction of a drug evaluation framework that could support regulatory approval, drug pricing, prescription decisions making, medical insurance reimbursement, and other related purposes
- Strategic Directions in System Formulary, Drug Policy, and High-Cost . . .
Health-system formulary and drug policy decision processes must assess reimbursement, site of care, and overall impact on the organization, especially for current and future high-complexity, high-cost medications
|
|
|